Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nordic Biotic India is a biotechnology company specializing in the development and commercialization of microbiome-based solutions, with a primary focus on the emerging field of psychobiotics. The company leverages research into the gut-brain axis to create targeted probiotic formulations designed to support mental health, stress management, and cognitive function. Their product portfolio includes specialized microbial strains aimed at addressing mood disorders, anxiety, and digestive health. Operating as the Indian subsidiary of the European-based Nordic Biotic, the firm integrates advanced microbial science into evidence-based nutraceuticals. Nordic Biotic India aims to bridge the gap between traditional probiotic supplementation and psychiatric care through clinically documented biotherapeutic products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nordic Biotic India.